EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Expression of hsv1-miR-H18 and hsv2-miR-H9 as a field defect marker for detecting prostate cancer

Young Joon Byun, Ho Won Kang, Xuan-Mei Piao, Chuang-Ming Zheng, Sung-Kwon Moon, Yung Hyun Choi, Won Tae Kim, Sang-Cheol Lee, Seok Joong Yun, Wun-Jae Kim

Prostate International · 2022-03 · 10 (1) · 1-6

DOI: 10.1016/j.prnil.2021.11.003 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Prostate International, 2022-03. Verfasst von Young Joon Byun und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, College of Medicine, Chungbuk National University, Cheongju, Korea. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Prostate-specific antigen (PSA) is a marker of prostate cancer (PCa), although its efficacy as a diagnostic marker remains controversial. A high false-positive rate leads to repeat biopsy in approximately 70% of patients, which may not be necessary. Epigenetic biomarkers of field cancerization have been investigated widely as promising tools for the diagnosis of patients with suspected tumors. In the current study, we examined the diagnostic value of two microRNA (miRNA) candidates, hsv1-miR-H18 and hsv2-miR-H9, using formalin-fixed paraffin-embedded (FFPE) tissues from patients with PCa or benign prostate hyperplasia (BPH) (as controls) to determine the usefulness of these markers for detecting the presence of cancer. METHODS: Expression of hsv1-miR-H18 and hsv2-miR-H9 in 201 FFPE tissues, including 52 primary tumors, 73 surrounding noncancerous tissues, and 90 BPH nontumor controls was examined by real-time PCR. RESULTS: Expression of hsv1-miR-H18 and hsv2-miR-H9 was significantly higher in primary tumors from PCa patients than in BPH controls (P < 0.0001). In patients within the PSA gray zone, the two viral miRNAs could distinguish PCa from controls with appropriate sensitivity and specificity. Expression of the two miRNAs did not differ between primary tumors and noncancerous surrounding tissues. CONCLUSIONS: The viral miRNAs hsv1-miR-H18 and hsv2-miR-H9 may be associated with field cancerization of PCa and could be promising supplemental biomarkers to the PSA assay to decrease the rate of unnecessary biopsy, particularly in patients within the PSA gray zone.

Schlagwörter

Stichwörter der Autor:innen

BiomarkersDiagnosisProstate neoplasmsProstate-specific antigenmicroRNAs

Autor:innen und Institutionen

  • Department of Urology, College of Medicine, Chungbuk National University, Cheongju, Korea.
  • Department of Urology, Chungbuk National University Hospital, Cheongju, Korea.
  • Department of Food Science and Technology, Chung-Ang University, Ansung, 456-756, Korea.
  • Department of Biochemistry, Dongeui University College of Oriental Medicine, Busan, Korea.
  • Institute of Urotech, Cheongju, 28644, Korea.

Zitieren

APA

Byun, Y. J., Kang, H. W., Piao, X. M., Zheng, C. M., Moon, S. K., Choi, Y. H., Kim, W. T., Lee, S. C., Yun, S. J., & Kim, W. J. (2022). Expression of hsv1-miR-H18 and hsv2-miR-H9 as a field defect marker for detecting prostate cancer. Prostate International, 10(1), 1-6. https://doi.org/10.1016/j.prnil.2021.11.003

Vancouver

Byun YJ, Kang HW, Piao XM, Zheng CM, Moon SK, Choi YH, et al. Expression of hsv1-miR-H18 and hsv2-miR-H9 as a field defect marker for detecting prostate cancer. Prostate International. 2022;10(1):1-6. doi:10.1016/j.prnil.2021.11.003

BibTeX
@article{Byun2022,
  author = {Byun, Young Joon and Kang, Ho Won and Piao, Xuan-Mei and Zheng, Chuang-Ming and Moon, Sung-Kwon and Choi, Yung Hyun and Kim, Won Tae and Lee, Sang-Cheol and Yun, Seok Joong and Kim, Wun-Jae},
  title = {Expression of hsv1-miR-H18 and hsv2-miR-H9 as a field defect marker for detecting prostate cancer},
  journal = {Prostate International},
  year = {2022},
  volume = {10},
  number = {1},
  pages = {1--6},
  doi = {10.1016/j.prnil.2021.11.003}
}
Kostenlos starten →